TRAVERE THERAPEUTICS INC

CUSIP: 89422GAA5 Class: Convertible Debt

Kohlberg Kravis Roberts & Co. L.P.'s Holding History (CIK: 0001399770)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,995,000 Value ($000) $2,847 Avg Close — Range —
Q3 2025
Shares 1,995,000 Value ($000) $2,259 Avg Close — Range —
Q2 2025
Shares 815,000 Value ($000) $778 Avg Close — Range —